cannelle de Cochinchine

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• amenorrhea [Insufficient Evidence]
• angina [Insufficient Evidence]
• common cold [Insufficient Evidence]
• diabetes mellitus [Insufficient Evidence]
• diarrhea [Insufficient Evidence]
• dyslipidemia [Insufficient Evidence]
• erectile dysfxn [Insufficient Evidence]
• HTN [Insufficient Evidence]
• impaired glucose tolerance [Insufficient Evidence]
• mosquito repellent [Insufficient Evidence]
• muscle cramps [Insufficient Evidence]
• nausea/vomiting [Insufficient Evidence]
• obesity [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• stroke prevention [Insufficient Evidence]
• urinary incontinence [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

diabetes mellitus

[Insufficient Evidence]

Dose: 0.12-14.4 g PO qd; Alt: 100 mg PO 4-5x/day

diarrhea

[Insufficient Evidence]

Dose: 1200 mg PO bid

impaired glucose tolerance

[Insufficient Evidence]

Dose: 250 mg PO bid; Alt: 456 mg PO qd

mosquito repellent

[Insufficient Evidence]

Dose: apply 5% cream topically

polycystic ovary syndrome

[Insufficient Evidence]

Dose: 500 mg PO tid

stroke prevention

[Insufficient Evidence]

Dose: 5 g PO qd; Start: w/in 24h of ischemia onset; Info: used w/ aspirin